Consensus Cardinal Health, Inc.

Equities

CAH

US14149Y1082

Market Closed - Nyse Other stock markets 04:00:02 2024-05-20 pm EDT			5-day change	1st Jan Change
98.46 ^USD	-0.63%		+0.43%	-2.32%

May. 17	JPMorgan Adjusts Cardinal Health Price Target to $111 From $119	MT
May. 15	Argus Adjusts Price Target on Cardinal Health to $115 From $120	MT

Evolution of the average Target Price on Cardinal Health, Inc.

Price target over the last 5 years

History of analyst recommendation changes

fa291192639970caa14.0srjDLrvzVZUx4QGDOWDPaQpF8HczjA6rRAXdVM2-nY.mPq5R4u4vxUShLZpaLayaJZMbfKWq2V83lJBMBx5zgG3g5VY1ZWKHhij4w~328bd2e185851b32e359cef4cbd120e3

Analyst Recommendations on Cardinal Health, Inc.

JPMorgan Adjusts Cardinal Health Price Target to $111 From $119	May. 17	MT
Argus Adjusts Price Target on Cardinal Health to $115 From $120	May. 15	MT
Deutsche Bank Adjusts Price Target on Cardinal Health to $110 From $116	May. 07	MT
Jefferies Cuts Cardinal Health's Price Target to $105 From $110	May. 06	MT
Wells Fargo Raises Cardinal Health's Price Target to $95 From $94	May. 03	MT
Baird Adjusts Price Target on Cardinal Health to $128 From $134	May. 03	MT
Leerink Partners Adjusts Cardinal Health Price Target to $120 From $118	May. 02	MT
Wells Fargo Adjusts Cardinal Health Price Target to $94 From $96	Apr. 29	MT
Evercore ISI Adjusts Cardinal Health's Price Target to $110 From $118, Keeps In Line Rating	Apr. 24	MT
Morgan Stanley Adjusts Cardinal Health's Price Target to $114 From $117, Maintains Overweight Rating	Apr. 23	MT
Leerink Partners Adjusts Price Target on Cardinal Health to $118 From $125	Apr. 22	MT
Cardinal Health says contracts with UnitedHealth's OptumRx will not be renewed	Apr. 22	RE
Cardinal Health will not renew contracts with OptumRx	Apr. 22	RE
Leerink Partners Starts Cardinal Health With Outperform Rating, $125 Price Target	Feb. 26	MT
Argus Upgrades Cardinal Health to Buy From Hold, Price Target is $120	Feb. 09	MT
UBS Adjusts Cardinal Health Price Target to $125 From $122, Maintains Buy Rating	Feb. 05	MT
UBS Raises Cardinal Health Price Target to $122 From $114, Maintains Buy Rating	Jan. 29	MT
Wells Fargo Starts Coverage on Cardinal Health with Underweight Rating, $96 Price Target	Dec. 14	MT
JPMorgan Raises Cardinal Health's Price Target to $112 From $101, Maintains Neutral Rating	Nov. 17	MT
Investors see life through rose-colored glasses	Nov. 17
ANALYST RECOMMENDATIONS : Air Products & Chemicals, Barclays, Glencore, Mastercard, Walmart...	Nov. 17
Deutsche Bank Raises Cardinal Health Price Target to $105 From $102, Maintains Hold Rating	Nov. 09	MT
UBS Adjusts Cardinal Health Price Target to $114 From $110, Maintains Buy Rating	Nov. 06	MT
ANALYST RECOMMENDATIONS : Asos, Blackstone, Fortinet, Hershey, Wizz Air...	23-09-27
ANALYST RECOMMENDATIONS : Microsoft, Oracle, Adobe, Qualcomm, 3M...	23-09-12

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

99.08 USD

Average target price

111.8 USD

Spread / Average Target

+12.82%

High Price Target

128 USD

Spread / Highest target

+29.19%

Low Price Target

92 USD

Spread / Lowest Target

-7.15%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cardinal Health, Inc.

JPMorgan Chase
Argus
Deutsche Bank Securities
Jefferies & Co.
Wells Fargo Securities
Baird
Leerink Partners
Evercore ISI
Morgan Stanley
UBS
Nephron Research
Morningstar
TD Cowen
Mizuho Securities
Citigroup
Barclays
Credit Suisse
Cowen
BofA Securities

Ratings for Cardinal Health, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar